i-Base home
Search Menu
  • Home
  • HTB
  • 2005
  • October

October 2005

Contents

Editorial

  • Volume 6 Number 10 October 2005

Conference reports

  • Further Reports from 3rd IAS Conference on AIDS Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005
  • Management of hepatitis C and B in HIV-coinfected individuals: an overview of studies presented at the 3rd IAS Conference
  • Highlights of HIV drug resistance studies presented at the 3rd IAS Conference

Antiretrovirals

  • GSK stops trials of CCR5 entry inhibitor GW873140 in naive patients
  • AZT comes off patent: generic versions approved for US market

Treatment access

  • Depletion of latent HIV-1 reservoir with valproic acid: interesting data but not a cure

Pregnancy

  • Breast milk, HIV suppression and decreased mother to child transmission
  • Single dose nevirapine infant prophylaxis to reduce mother to child transmission may have similar efficacy to maternal and infant doses

Paediatric care

  • Pharmacokinetics of nevirapine in HIV positive children receiving Thai fixed dose combination

Side effects

  • Fatigue among HIV-positive patients in the era of highly active antiretroviral therapy

Other news

  • WHO – Patients for patient safety: call for participants
  • Does buprenorphine have a role in preventing HIV transmission and treating HIV-infected IDUs?

On the web

  • Medscape articles and online papers
  • Neurological complications of HIV infection
  • HIV inSite Knowledge Base
  • WHO list of essential medicines

PDFs

  • Volume 6 Number 10 October 2005 PDF
  • HTB RSS

Early access

  • US CDC updated guidelines on PEP (May 2025) 10 May 2025
  • Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025
  • The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025
  • Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Reduced dosing: a possible crisis response to ART stockouts and closed clinics 5 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook